Hosted on MSN1mon
Globus Medical strengthens SCS market position with $250m Nevro deal
Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...
Nasdaq1mon
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?
Nevro’s comprehensive HFX spinal cord stimulation (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic ...